1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview and Dynamics
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Global Brain Monitoring Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
3.6 Technological Landscape
3.7 Impact of COVID-19 on Global Brain Monitoring Market
4 Product Overview
4.1 Introduction
4.1.1 Market Size & Forecast (Value)
4.2 Device
4.2.1 Market Size & Forecast (Value)
4.2.1.1 Computerized Tomography (CT) Scanners
4.2.1.2 Magnetic Resonance Imaging (MRI) Scanners
4.2.1.3 Positron Emission Tomography (PET) Scanners
4.2.1.4 Electroencephalograph (EEG) Devices
4.2.1.5 Electromyography (EMG) Devices
4.2.1.6 Magnetoencephalography (MEG) Devices
4.2.1.7 Transcranial Doppler (TCD) Devices
4.2.1.8 Sleep Monitoring Devices
4.2.1.9 Intracranial Pressure (ICP) Monitors
4.2.1.10 Cerebral Oximeters
4.3 Accessories
4.3.1 Market Size & Forecast (Value)
4.3.1.1 Electrodes
4.3.1.2 Sensors
4.3.1.3 Caps
4.3.1.4 Pastes & Gels
4.3.1.5 Batteries
4.3.1.6 Others
5 Application Overview
5.1 Introduction
5.1.1 Market Size & Forecast (Value)
5.2 Parkinson’s Disease
5.2.1 Market Size & Forecast (Value)
5.3 Traumatic Brain Injury
5.3.1 Market Size & Forecast (Value)
5.4 Epilepsy
5.4.1 Market Size & Forecast (Value)
5.5 Dementia
5.5.1 Market Size & Forecast (Value)
5.6 Stroke
5.6.1 Market Size & Forecast (Value)
5.7 Other Applications
5.7.1 Market Size & Forecast (Value)
6 End-User Overview
6.1 Introduction
6.1.1 Market Size & Forecast (Value)
6.2 Hospitals
6.2.1 Market Size & Forecast (Value)
6.3 Neurology Centers
6.3.1 Market Size & Forecast (Value)
6.4 Diagnostic Centers
6.4.1 Market Size & Forecast (Value)
6.5 Other End-Users
6.5.1 Market Size & Forecast (Value)
7 Regional Overview
7.1 Introduction
7.1.1 Market Size & Forecast (Value)
7.2 Americas
7.2.1 North America
7.2.1.1 The U.S.
7.2.1.1.1 By Product
7.2.1.1.2 By Application
7.2.1.1.3 By End-User
7.2.1.2 Canada
7.2.1.2.1 By Product
7.2.1.2.2 By Application
7.2.1.2.3 By End-User
7.2.2 South America
7.2.2.1 By Product
7.2.2.2 By Application
7.2.2.3 By End-User
7.3 Europe
7.3.1 Market Size & Forecast (Value)
7.3.2 Western Europe
7.3.2.1 The U.K.
7.3.2.1.1 By Product
7.3.2.1.2 By Application
7.3.2.1.3 By End-User
7.3.2.2 Germany
7.3.2.2.1 By Product
7.3.2.2.2 By Application
7.3.2.2.3 By End-User
7.3.2.3 France
7.3.2.3.1 By Product
7.3.2.3.2 By Application
7.3.2.3.3 By End-User
7.3.2.4 Spain
7.3.2.4.1 By Product
7.3.2.4.2 By Application
7.3.2.4.3 By End-User
7.3.2.5 Italy
7.3.2.5.1 By Product
7.3.2.5.2 By Application
7.3.2.5.3 By End-User
7.3.3 Eastern Europe
7.3.3.1 By Product
7.3.3.2 By Application
7.3.3.3 By End-User
7.3.4 The Rest of Europe
7.3.4.1 By Product
7.3.4.2 By Application
7.3.4.3 By End-User
7.4 Asia-Pacific
7.4.1 Market Size & Forecast (Value)
6.4.2 Japan
7.4.2.1 By Product
7.4.2.2 By Application
7.4.2.3 By End-User
7.4.3 China
7.4.3.1 By Product
7.4.3.2 By Application
7.4.3.3 By End-User
7.4.4 Australia
7.4.4.1 By Product
7.4.4.2 By Application
7.4.4.3 By End-User
7.4.5 India
7.4.5.1 By Product
7.4.5.2 By Application
7.4.5.3 By End-User
7.4.6 South Korea
7.4.6.1 By Product
7.4.6.2 By Application
7.4.6.3 By End-User
7.4.7 The Rest of Asia-Pacific
7.4.7.1 By Product
7.4.7.2 By Application
7.4.7.3 By End-User
9.5 The Middle East and Africa
9.5.1 The Middle East and Africa
9.5.1.1 By Product
9.5.1.2 By Application
9.5.1.3 By End-User
10 Company Profile
10.1 Medtronic Plc.
10.1.1 Company Overview
10.1.2 Financial Performance
10.1.3 Recent Developments
10.1.4 Product Portfolio
10.2 Nihon Kohden Corporation
10.2.1 Company Overview
10.2.2 Financial Performance
10.2.3 Recent Developments
10.2.4 Product Portfolio
10.3 Philips Healthcare
10.3.1 Company Overview
10.3.2 Financial Performance
10.3.3 Recent Developments
10.3.4 Product Portfolio
10.4 GE Healthcare
10.4.1 Company Overview
10.4.2 Financial Performance
10.4.3 Recent Developments
10.4.4 Product Portfolio
10.5 Siemens Healthineers
10.5.1 Company Overview
10.5.2 Financial Performance
10.5.3 Recent Developments
10.5.4 Product Portfolio
10.6 Advanced Brain Monitoring
10.6.1 Company Overview
10.6.2 Financial Performance
10.6.3 Recent Developments
10.6.4 Product Portfolio
10.7 Masimo Corporation
10.7.1 Company Overview
10.7.2 Financial Performance
10.7.3 Recent Developments
10.7.4 Product Portfolio
10.8 NeuroWave Systems Inc.
10.8.1 Company Overview
10.8.2 Financial Performance
10.8.3 Recent Developments
10.8.4 Product Portfolio
10.9 Resmed, Inc.
10.9.1 Company Overview
10.9.2 Financial Performance
10.9.3 Recent Developments
10.9.4 Product Portfolio
10.10 Natus medical Incorporated
10.10.1Company Overview
10.10.2Financial Performance
10.10.3Recent Developments
10.10.4Product Portfolio
11 Conclusion & Recommendations
12 Acronyms & Abbreviations
Copyright . All rights Reserved By Straits Research